Combined Approaches to Early ADME/Tox Screening

Compound selection decisions are being pushed earlier and earlier in drug discovery to reduce the crippling cost of late stage failures. Whilst ADME/Tox tools are still developing and improving, it is critical that these technologies are harnessed and integrated effectively to guide discovery projects.

Attend Combined Approaches to Early ADME/Tox Screening to explore how to apply and integrate in silico, in vitro and in vivo tools and make sure that you are using your ADME/Tox capability to maximum effect.

Further Information: http://www.iqpc.co.uk/GB-2762//COMBICHEM